rs370444838
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PP5_Very_Strong
The NM_005956.4(MTHFD1):c.146C>T(p.Ser49Phe) variant causes a missense change. The variant allele was found at a frequency of 0.000193 in 1,612,804 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_005956.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000127 AC: 32AN: 251122Hom.: 0 AF XY: 0.000169 AC XY: 23AN XY: 135766
GnomAD4 exome AF: 0.000203 AC: 296AN: 1460654Hom.: 0 Cov.: 30 AF XY: 0.000201 AC XY: 146AN XY: 726766
GnomAD4 genome AF: 0.000105 AC: 16AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74330
ClinVar
Submissions by phenotype
Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia Pathogenic:3
This variant is interpreted as Likely Pathogenic, for Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia, autosomal recessive. The following ACMG Tag(s) were applied: PP3 => Multiple lines of computational evidence support a deleterious effect on the gene or gene product. PS3 => Well-established functional studies show a deleterious effect (https://www.ncbi.nlm.nih.gov/pubmed/25633902). PP1 => Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease (https://www.ncbi.nlm.nih.gov/pubmed/25633902). PM3 => For recessive disorders, detected in trans with a pathogenic variant (https://www.ncbi.nlm.nih.gov/pubmed/25633902). PM2-Supporting => PM2 downgraded in strength to Supporting. -
- -
- -
Severe combined immunodeficiency disease Pathogenic:1
Variant summary: MTHFD1 c.146C>T (p.Ser49Phe) results in a non-conservative amino acid change located in the Tetrahydrofolate dehydrogenase/cyclohydrolase, catalytic domain (IPR020630) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00013 in 251122 control chromosomes (gnomAD v2.1, exomes dataset). This frequency is not higher than the maximum expected for a pathogenic variant in MTHFD1 causing Severe Combined Immunodeficiency Syndrome (0.00035), allowing no conclusion about variant significance. c.146C>T has been reported in the literature in at least 5 individuals from two families who were affected with combined immunodeficiency and megaloblastic anemia (Burda_2015, Bidla_2020), of note the variant co-segregated with disease in these families. These data indicate that the variant is likely to be associated with disease. Publications also reports experimental evidence evaluating an impact on protein function, and demonstrated severely decreased enzyme activity in patient derived fibroblast (Burda_2015, Bidla_2020). Four submitters have provided clinical-significance assessments for this variant in ClinVar after 2014, and classified the variant as pathogenic (n=2) / likely pathogenic (n=1) or VUS (n=1). Based on the evidence outlined above, the variant was classified as pathogenic. -
Neural tube defects, folate-sensitive;C4540434:Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia Pathogenic:1
- -
not provided Pathogenic:1
This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 49 of the MTHFD1 protein (p.Ser49Phe). This variant is present in population databases (rs370444838, gnomAD 0.02%). This missense change has been observed in individual(s) with methylenetetrahydrofolate dehydrogenase 1 deficiency (PMID: 25633902, 32414565). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 446306). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt MTHFD1 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at